Drug-induced cutaneous pathology

Journal of Clinical Pathology

Volumn 62, Issue 6, 2009, Pages 493-504

  Ramdial, Pratistadevi K ^a,c   Naidoo, D K ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Dermatology and Skin Care Institute   (South Africa)

^c INKOSI ALBERT LUTHULI CENTRAL HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOGLUTETHIMIDE; AMINOGLYCOSIDE DERIVATIVE; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; CAPTOPRIL; CARBAMAZEPINE; CARBROMAL; CARBUTAMIDE; CEPHALOSPORIN DERIVATIVE; CHLORDIAZEPOXIDE; CONTRAST MEDIUM; CYCLOSPORIN A; DIURETIC AGENT; GLIPIZIDE; GRISEOFULVIN; HYDANTOIN DERIVATIVE; IOHEXOL; KETOCONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; PENICILLIN G; PHENYTOIN; PSORALEN DERIVATIVE; STEROID; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ACNE; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; BULLOUS PEMPHIGOID; CANCER CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; ERYTHEMA MULTIFORME; FIXED DRUG ERUPTION; FOLLICULITIS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; LICHENOID ERUPTION; PANNICULITIS; PEMPHIGUS; PHOTOSENSITIVITY; PIGMENTED PURPURIC DERMATOSIS; PITYRIASIS ROSEA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PSEUDOLYMPHOMA; PSORIASIS; PUSTULOSIS; RASH; REVIEW; SCLERODERMA; SKIN BIOPSY; SKIN GRANULOMA; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS; VESICULAR RASH;

DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; SKIN;

EID: 67649224541     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.058289     Document Type: Review

References (150)

1. Martin T, Hui LI. Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin Med J 2008;121:756-761
2. Atzori L, Pinna AL, Ferreli C, et al. Pityriasis rosea-like adverse reaction: Review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J 2008;12:1-6.
3. Justiniano H, Berlingeri-Ramos AC, Sanchez JL. Pattern analysis of drug-induced skin diseases. Am J Dermatopathol 2008;30:352-369
4. Crowson AN, Brown TJ, Magro CM. Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions. Am J Clin Dermatol 2003;4:407-428
5. Weedon D. Cutaneous drug reactions. In: Weedon D, ed. Skin Pathology. 2nd edn. Edinburgh: Churchill Livingstone, 2002:581-592
6. Diaz-Jara M, Tornero P, Barrio MDE, et al. Pigmented purpuric dermatosis due to pseudoephedrine. Contact Dermatitis 2002;46:300-301 (Pubitemid 34753735)
7. Abeck D, Gross GE, Kuwert C, et al. Acetaminophen-induced progressive pigmentary purpura (Schamberg's disease). J Am Acad Dermatol 1992;27:123-124
8. Adams BB, Gadenne AS. Glipizide-induced pigmented purpuric dermatosis. J Am Acad Dermatol 1999;41:827-829 (Pubitemid 29513998)
9. Yung A, Goulden V. Pigmented purpuric dermatosis (capillaritis) induced by bezafibrate. J Am Acad Dermatol 2005;53:168-169 (Pubitemid 40826718)
10. Crowson AN, Magro CM, Zahorchak R. Atypical pigmentary purpura: a clinical, histopathologic, and genotypic study. Hum Pathol 1999;30:1004-1012 (Pubitemid 29427155)
11. Ratnam KV, Su WPD, Peters MS. Purpura simplex (inflammatory purpura without vasculitis). J Am Acad Dermatol 1991;25:642-647
12. Tsao H, Lerner LH. Pigmented purpuric eruption associated with injection medroxyprogesterone acetate. J Am Acad Dermatol 2000;43:308-310 (Pubitemid 30626011)
13. Kozel MMA, Mekkes JR, Bossuyt PMM, et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998;134:1575-1580 (Pubitemid 29009259)
14. Tutar E, Ekici F, Nacar N, et al. Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis. Rheumatol 2004;43:674-675 (Pubitemid 38628208)
15. Kränke B, Mayr-Kanhäuser S. Urticarial reaction to the antihistamine levocetirizine dihydrochloride. Dermatol 2005;210:246-247 (Pubitemid 40529246)
16. Chang YS, Kwon HS, Cho SH, et al. A case of urticaria induced by both hydroxyzine and cetirizine but not by levocetirizine. Allergy 2007;62:819-821 (Pubitemid 46934360)
17. Atzori L, Ferreli C, Pinna AL, et al. Pityriasis rosea-like adverse reaction to lisinopril. Eur Acad Dermatol Venereol 2004;18:736-748 (Pubitemid 39429730)
18. Kaplan B, Grunwald MH, Halevy S. Pityriasis rosea-like eruption associated with BCG vaccination. Isr J Med Sci 1989;25:570-572 (Pubitemid 19272773)
19. Buckley C. Pityriasis rosea-like eruption in a patient receiving omeprazole. Br J Dermatol 1996;135:652-668 (Pubitemid 26340296)
20. Brazzelli V, Prestinari F, Roveda E, et al. Pityriasis rosea-like eruption during treatment with imatinib mesylate. J Am Acad Dermatol 2005;53:S240-3.
21. Mavarkar L. Pityriasis rosea occurring during acyclovir therapy. Ind J Dermatol Vener Leprol 2007;73:200-201 (Pubitemid 46918523)
22. Wilkinson SM, Smith AG, Davis MJ, et al. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis 1992;51:881-884
23. Gonzalez E, Gonzalez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996;35:871-885 (Pubitemid 26422109)
24. Moore DE. Drug-induced cutaneous photosensitivity. Drug Safety 2002;25:345-372
25. Gupta AK, Sibbald RG, Knowles SR, et al. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug-induced psoriasis. J Am Acad Dermatol 1997;36:858-862 (Pubitemid 27220422)
26. Wolfe JT, Singh A, Lessin SR, et al. De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma. J Am Acad Dermatol 1995;32:887-893
27. Tan B, Foley P. Guttate psoriasis following ecstasy ingestion. Austr J Dermatol 2004;45:167-169 (Pubitemid 39071028)
28. Sfikakis PP, Iliopoulos A, Elezoglou A, et al. Psoriasis induced by anti-tumor necrosis factor therapy. Arth Rheum 2005;52:2513-2518
29. Zohdi-Mofid M, Horn TD. Acrosyringeal concentration of necrotic keratinocytes in erythema multiforme: a clue to drug etiology. Clinicopathologic review of 29 cases. J Cutan Pathol 1997;24:235-240 (Pubitemid 27187020)
30. Callaly EL, FitzGerald O, Rogers S. Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis. Clin Exp Dermatol 2008;33:572-574
31. Wolf R, Orion E, Davidovici B. Toxic epidermal necrolysis caused by tetrazepam. Int J Dermatol 2006;45:1260-1261 (Pubitemid 44560394)
32. Akosa AB, Elhag AM. Toxic epidermal necrolysis: a study of the sweat glands. J Cutan Pathol 1995;22:359-364
33. McKee PH, Calonje E, Granter SR. Cutaneous adverse reactions to drugs. In: McKee PH, Calonje E, Granter SR, eds. Pathology of the skin with clinical correlations. 3rd edn. Philadelphia: Elsevier, 2005:623-671
34. Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ("Hand-Foot") Syndrome. Am J Clin Dermatol 2000;1:225-234
35. Webster-Gandy JD, How C, Harrold K. Palmar-plantar erythrodysesthesia (PPE). Eur J Oncol Nurs 2007;11:238-246
36. Janusch M, Fischer M, Marsch WCh, et al. The hand-foot syndrome - a frequent secondary manifestation in antineoplastic chemotherapy. Eur J Dermatol 2006;16:494-499 (Pubitemid 44861822)
37. Suwattee P, Chow S, Berg BC, et al. Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis. Arch Dermatol 2008;144:123-125 (Pubitemid 351159411)
38. Yang CH, Lin WC, Chuang CK, et al. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. Br J Dermatol 2008;158:592-596 (Pubitemid 351239162)
39. Sehgal VN, Srivastava G. Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol 2006;45:897-908. (Pubitemid 44145022)
40. Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998;37:833-838 (Pubitemid 28545276)
41. Özkaya-Bayazit E. Specific site involvement in fixed drug eruption. J Am Acad Dermatol 2003;49:1003-1007 (Pubitemid 37475469)
42. Zanolli MD, McAlvany J, Krowchuk DP. Phenolphthalein-induced fixed drug eruption: a cutaneous complication of laxative use in a child. Paediatrics 1993;91:1199-1201 (Pubitemid 23165806)
43. Alanko K, Kanerva L, Mohell-Talolahti M, et al. Non-pigmented fixed drug eruption from pseudoephedrine. J Am Acad Dermatol 1996;35:647-648 (Pubitemid 26427083)
44. Young PC, Montemarano AD, Lee N, et al. Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption. J Am Acad Dermatol 1996;34:313-314 (Pubitemid 26064012)
45. Vilaplana J, Romaguera C. Fixed drug eruption from sodium benzoate. Contact Dermat 2004;49:290-291
46. Fiszenson-Albala F, Anzerie V, Mahe E, et al. A 6 month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018-1022 (Pubitemid 37541988)
47. Hernández-Salazar A, Ponce-de-León Rosales S, Rangel-Frausto S, et al. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalised patients. Arch Med Res 2006;37:899-902.
48. Cetkovská P, Pizinger K. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. Int J Dermatol 2006;45:320-322 (Pubitemid 43337653)
49. Cameron HA, Ramsay LE. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J 1984;289:410-412 (Pubitemid 14010304)
50. Pavlidakey GP, Hashimoto K, Heller GL, et al. Chlorpromazine-induced lupus like disease. Case report and review of the literature. J Am Acad Dermatol 1985;13:109-115 (Pubitemid 15068688)
51. Reed BR, Huff JC, Jones SK, et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Int Med 1985;103:49-51. (Pubitemid 15068498)
52. Magro CM, Crowson AN, Harrist TJ. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br J Dermatol 1996;134:855-862 (Pubitemid 26150283)
53. Goebel C, Vogel C, Wulferink M, et al. Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages. Chem Res Toxicol 1999;12:488-500. (Pubitemid 29282919)
54. Balestrero S, Ciambellotti A, Parodi A, et al. Minocycline-induced lupus-like syndrome. Int J Dermatol 2001;40:472-484 (Pubitemid 32982307)
55. Stratigos AJ, Antoniou C, Stamathioudaki S, et al. Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 2004;29:150-153 (Pubitemid 38367198)
56. Benucci M, Gobbi FL, Fossi F, et al. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. J Clin Rheumatol 2005;11:47-49 (Pubitemid 40223880)
57. Kang M-J, Lee Y-H, Lee J. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis. J Korean Med Sci 2006;21:946-949 (Pubitemid 44611236)
58. Spillane AP, Xia Y, Sniezek PJ. Drug-induced lupus erythematosus in a patient treated with adalumimab. J Am Acad Dermatol 2007;56:S114-6. (Pubitemid 46552083)
59. Van der Haute V, Antoine JL, Lachapelle JM. Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 1989;179:10-13 (Pubitemid 19172329)
60. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol 1993;29:249-255 (Pubitemid 23221906)
61. Dalmau J, Peramiquel L, Puig L, et al. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect. Br J Dermatol 2006;154:1213-1216 (Pubitemid 43727416)
62. Hague JS, Ilchyshyn A. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer. Clin Exp Dermatol 2006;32:102-103
63. Pérez-Pérez L, Cabanillas M, Pereiro Ferreirós MM, et al. Photosensitive lichenoid eruption and inhaled tiotropium bromide. Dermatol 2007;214:97-98 (Pubitemid 46033010)
64. Böer A, Tirumalae R, Bresch M, et al. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies. Br J Dermatol 2008;159:394-402. (Pubitemid 352009859)
65. Crowson AN, Magro CM. Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin 1999;17:537-560 (Pubitemid 29316163)
66. Albrecht J, Fine LA, Piette W. Drug-associated lymphoma and pseudolymphoma: recognition and management. Dermatol Clin 2007;25:233-244 (Pubitemid 46553774)
67. D'Incan M, Souteyrand P, Bignon YJ, et al. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome. Arch Dermatol 1992;128:1371-1374
68. Holm N, Flaig MJ, Yazadi AS, et al. The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol 2002;29:447-452 (Pubitemid 35034454)
69. Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 1998;25:72-78 (Pubitemid 28073644)
70. Perrin C, Lacour J-P, Castanet J, et al. Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis. Am J Dermatopathol 2001;23:295-298 (Pubitemid 32729437)
71. Alvarez-Ruiz S, Peñas PF, Fernández-Herrera J, et al. Maculopapular eruption with enlarged macrophages in eight patients receiving G-CSF or GM-CSF. J Eur Acad Dermatol Venereol 2004;18:310-313 (Pubitemid 38618327)
72. Deng A, Harvey V, Sina B, et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor a inhibitors. Arch Dermatol 2006;142:198-202. (Pubitemid 43276531)
73. Fujita Y, Shimizu T, Shimizu H. A case of interstitial granulomatous drug reaction due to sennoside. Br J Dermatol 2004;150:1028-1054 (Pubitemid 38903547)
74. Lee H-W, Yun W-J, Lee M-W, et al. Interstitial granulomatous drug reaction caused by Chinese herbal medication. J Am Acad Dermatol 2005;52:712-713 (Pubitemid 40585456)
75. Lee M-W, Choi J-H, Sung K-J, et al. Interstitial and granulomatous drug reaction presenting as erythema nodosum-like lesions. Acta Derm Venereol 2002;82:473-474 (Pubitemid 36140257)
76. Lim AC, Hart K, Murrell D. A granuloma annulare-like eruption associated with the use of amlodipine. Austr J Dermatol 2002;43:24-27 (Pubitemid 34155481)
77. Scott GA. Report of three cases of cutaneous reactions to granulocyte macrophage-colony-stimulating factor and a review of the literature. Am J Dermatopathol 1995;17:107-114
78. Valks R, Vargas E, Muñoz E, et al. Dermal infiltrate of enlarged macrophages in patients receiving chemotherapy. J Cutan Pathol 1998;25:259-264 (Pubitemid 28306515)
79. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996;34:918-923 (Pubitemid 26143882)
80. Sáez M, García-Bustínduy M, Noda A, et al. Drug-induced Sweet's syndrome. J Eur Acad Dermatol Venereol 2004;18:233. (Pubitemid 38379918)
81. Tan AW, Tan H-H, Lim PL. Bullous Sweet's syndrome following influenza vaccination in a HIV-infected patient. Int J Dermatol 2006;45:1254-1255 (Pubitemid 44560390)
82. Waldman MA, Black DR, Callen JP. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol 2004;29:633-636 (Pubitemid 39573655)
83. Wiadrowski TP, Reid CM. Drug-induced linear IgA bullous disease following antibiotics. Austr J Dermatol 2001;42:196-199 (Pubitemid 32721562)
84. Armstrong AW, Fazeli A, Yeh SW, et al. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme. J Cutan Pathol 2004;31:393-397 (Pubitemid 38530126)
85. Kuechle MK, Stegemeir E, Maynard B, et al. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 1994;30:187-192 (Pubitemid 24051881)
86. Nousari HC, Kimyai-Asadi A, Caeiro JP, et al. Clinical, demographic and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin: report of 2 cases and review of the literature. Medicine (Baltimore) 1999;78:1-8. (Pubitemid 29065976)
87. Plunkett RW, Chiarello SE, Beutner EH. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. J Am Acad Dermatol 2001;45:691-696 (Pubitemid 33032564)
88. Primka EJ, Liranzo MO, Bergfeld WF, et al. Amiodarone-induced linear IgA disease. J Am Acad Dermatol 1994;31:809-811 (Pubitemid 24340759)
89. Yawalkar N, Reimers A, Hari Y, et al. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone-and metronidazole-specific T cells. Dermatology 1999;199:25-30. (Pubitemid 29366783)
90. Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998;16:393-397 (Pubitemid 28287773)
91. Ghaffarpour G, Jalali MHA, Yaghmaii B, et al. Chloroquine/ hydroxychloroquine-induced pemphigus. Int J Dermatol 2006;45:1261-1263 (Pubitemid 44560395)
92. Pisani M, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1986;4:118-132
93. Brenner S, Bialy-Golan A, Anhalt GJ. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 1997;36:919-923 (Pubitemid 27265902)
94. Campagne G, Roca M, Martinez A. Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect. Eur J Obstet Gynae Reprod Biol 2003;109:224-227 (Pubitemid 36809137)
95. Landau M, Brenner S. Histopathologic findings in drug-induced pemphigus. Am J Dermatopathol 1997;19:1-5. (Pubitemid 27467171)
96. Wolf R, Ruocco V. Gaining more insight into the pathomechanisms of thiol-induced acantholysis. Med Hypotheses 1997;48:107-110 (Pubitemid 27091225)
97. Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 1998;16:379-387 (Pubitemid 28287771)
98. Alcalay J, David M, Ingber A, et al. Bullous pemphigoid mimicking bullous erythema multiforme: an untoward side effect of penicillins. J Am Acad Dermatol 1988;18:345-349 (Pubitemid 18061205)
99. Van Joost Th, Crone RA, Overdijk AD. Ocular cicatricial pemphigoid associated with practolol therapy. Br J Dermatol 1976;94:447-450
100. Van Joost Th, Faber WR, Manuel HR. Drug-induced anogenital cicatricial pemphigoid. Br J Dermatol 1980;102:715-718 (Pubitemid 10086828)
101. Czechowicz RT, Reid CM, Warren LJ, et al. Bullous pemphigoid induced by cephalexin. Austr J Dermatol 2001;42:132-135 (Pubitemid 32436770)
102. Mehravaran M, Gyulai R, Husz S, et al. Drug-induced erythema multiforme-like bullous pemphigoid. Acta Derm Venereol 1999;79:233-254 (Pubitemid 29251515)
103. Borroni G, Brazzeli V, Baldini F, et al. Flutamide-induced pseudoporphyria. Br J Dermatol 1998;138:711-712 (Pubitemid 28212270)
104. Tolland JP, McKeown PP, Corbett JR. Voriconazole-induced pseudoporphyria. Photodermatol Photoimmunol Photomed 2007;23:29-31. (Pubitemid 46189304)
105. Antony F, Layton AM. Nabumetone-associated pseudoporphyria. Br J Dermatol 2000;142:1067-1068 (Pubitemid 30304644)
106. Breier F, Feldmann R, Pelzl M, et al. Pseudoporphyria cutanea tarda induced by furosemide in a patient undergoing peritoneal dialysis. Dermatology 1998;197:271-273 (Pubitemid 28445830)
107. Epstein JH, Tuffanelli DL, Seibert JS, et al. Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization. Arch Dermatol 1976;112:661-666
108. Judd L. Pseudoporphyria due to Cola. Int J Dermatol 1991;30:674-675
109. Markus R, Reddick ME, Rubenstein MC. Rofecoxib-induced pseudoporphyria. J Am Acad Dermatol 2004;50:647. (Pubitemid 38393183)
110. McDonagh AJG, Harrington CI. Pseudoporphyria complicating etretinate therapy. Clin Exp Dermatol 1989;14:437-438 (Pubitemid 19278991)
111. Meggitt SJ, Farr PM. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs. Br J Dermatol 1999;141:573-609.
112. O'Donoghue NB, Higgins EM. Naproxen-induced pseudoporphyria. Clin Exp Dermatol 2002;27:339-340
113. Phung TL, Pipkin CA, Tahan SR, et al. β-Lactam antibiotic-induced pseudoporphyria. J Am Acad Dermatol 2004;51:S80-2. (Pubitemid 38954018)
114. Poh-Fitzpatrick MB. Porphyria, pseudoporphyria, pseudopseudoporphyria...? Arch Dermatol 1986;122:403-404
115. Beltraminelli HS, Lerch M, Arnold A, et al. Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature. Br J Dermatol 2005;152:780-783 (Pubitemid 40571315)
116. Beylot C, Doutre M-S, Beylot-Barry M. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg 1996;15:244-249 (Pubitemid 27197963)
117. Byerly FL, Nelson KC, Granko RP, et al. Valdecoxib-associated acute generalized exanthematous pustulosis. Burns 2005;31:383-387 (Pubitemid 40363953)
118. Häusermann P, Scherer K, Weber M, et al. Ciprofloxacin-induced acute generalized exanthematous pustulosis mimicking bullous drug eruption confirmed by a positive patch test. Dermatology 2005;211:277-280 (Pubitemid 41415870)
119. Heinemann C,Wiesend CL, Hipler C, et al. Acute generalized exanthematous pustulosis (AGEP) after oral use of amphotericin B. J Am Acad Dermatol 2007;57:S61-3. (Pubitemid 47048444)
120. Mengesha YM, Bennett ML. Pustular skin disorders. Am J Clin Dermatol 2002;3:389-400.
121. Sidoroff A, Halevy S, Bavinck JNB, et al. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol 2001;28:113-119 (Pubitemid 32112994)
122. Yesudian PD, Penny M, Azurdia RM, et al. Ibuprofen-induced acute generalized exanthematous pustulosis. Int J Dermatol 2004;43:208-210 (Pubitemid 38425670)
123. Sovia C, Allegue F, Espana A, et al. Vegetating iododerma with underlying systemic diseases: report of three cases. J Am Acad Dermatol 1990;22:418-422 (Pubitemid 20212393)
124. Boudoulas O, Siegle RJ, Grimwood RE. Iododerma occurring after orally administered iopanoic acid. Arch Dermatol 1987;123:387-388 (Pubitemid 17024682)
125. Carlson JA, Ng BT, Chen K-R. Cutaneous vasculitis update: Diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005;27:504-528 (Pubitemid 44383995)
126. García-Porrúa C, Llorca J, González-Louzao C, et al. Hypersensitivity vasculitis in adults: a benign disease usually limited to skin. Clin Exp Rheumatol 2001;19:85-88 (Pubitemid 32203853)
127. Kluger N, Pagnoux C, Guillevin L, et al. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis. Br J Dermatol 2008;159:615-620
128. Galimont-Collen AFS, Vos LE, Lavrijsen APM, et al. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors. Eur J Cancer 2007;43:845-851 (Pubitemid 46366684)
129. Kunzle N, Venetz J-P, Pascual M, et al. Sirolimus-induced acneiform eruption. Dermatol 2005;211:366-369 (Pubitemid 41642115)
130. DeWitt CA, Siroy AE, Stone SP. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol 2007;56:500-505 (Pubitemid 46273854)
131. Journagan S, Obadiah J. An acneiform eruption due to erlotinib: Prognostic implications and management. J Am Acad Dermatol 2006;54:358-360 (Pubitemid 43144418)
132. Lee H-H, Song I-H, Friedrich M, et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-a antagonists. Br J Dermatol 2007;156:486-491 (Pubitemid 46253946)
133. Laing ME, Laing TA, Mulligan NJ, et al. Eosinophilic pustular folliculitis induced by chemotherapy. J Am Acad Dermatol 2006;54:729-730
134. Maejima H, Mukai H, Hikaru E. Eosinophilic pustular folliculitis induced by allopurinol and timepidium bromide. Acta Derm Venereol 2002;82:316-317 (Pubitemid 35015063)
135. Mizoguchi S, Setoyama M, Higashi Y, et al. Eosinophilic pustular folliculitis induced by carbamazepine. J Am Acad Dermatol 1998;38:641-643 (Pubitemid 28182944)
136. Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol 2004;5:189-197 (Pubitemid 38901548)
137. Mizukawa Y, Shiohara T. Eosinophilic pustular folliculitis induced after prolonged treatment with systemic corticosteroids in a patient with pustulosis palmoplantaris. Acta Derm Venereol 1998;78:221-222 (Pubitemid 28212296)
138. Ooi CG, Walker P, Sidhu SK, et al. Allopurinol induced generalized eosinophilic pustular folliculitis. Austr J Dermatol 2006;47:270-273 (Pubitemid 44536223)
139. Cleveland MG, Ajaikumar BS, Reganti R. Cutaneous fibrosis induced by docetaxel. A case report. Cancer 2000;88:1078-1081
140. Ferzli GT, EI-Tal A, Kibbi A-G, et al. Localised morphea: a rare adverse effect of valproic acid. Pediatr Neurol 2003;29:253-255 (Pubitemid 37415262)
141. Itoh M, Yanaba K, Kobayashi T, et al. Taxane-induced scleroderma. Br J Dermatol 2007;156:363-367 (Pubitemid 46095967)
142. King SL, Lichtler AC, Rowe DW, et al. Bleomycin stimulates pro-α1(I) collagen promoter through transforming growth factor β response element by intracellular and extracellular signaling. J Biol Chem 1994;269:13156-13161
143. Leshin B, Piette WW, Caplan RM. Morphea after bromocriptine therapy. Int J Dermatol 1989;28:177-179 (Pubitemid 19114131)
144. Kluger N, Girard C, Bessis D, et al. Methysergide-induced scleroderma-like changes of the legs. Br J Dermatol 2005;153:224-225 (Pubitemid 41044565)
145. Kupfer I, Balguerie X, Courville P, et al. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 2003;48:279-281 (Pubitemid 36232332)
146. Assouline S, Laneuville P, Gambacorti-Passerini C. Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia. N Engl J Med 2006;354:2623-2624 (Pubitemid 43882376)
147. Dellaripa PF, Wechsler ME, Roth ME, et al. Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents. Mayo Clin Proc 2000;75:643-645 (Pubitemid 30395929)
148. Jagdeo J, Campbell R, Long T, et al. Sweet's syndrome-like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia. J Am Acad Dermatol 2007;56:690-693 (Pubitemid 46400172)
149. Ugurel S, Lahaye T, Hildenbrand R, et al. Panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib. Br J Dermatol 2003;149:678-679 (Pubitemid 37281620)
150. Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 2001;45:163-183